640 results on '"Van Engelen, Baziel G. M."'
Search Results
2. The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
3. Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy
4. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers
5. Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood
6. The socioeconomic burden of facioscapulohumeral muscular dystrophy
7. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
8. Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study
9. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial
10. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
11. Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools
12. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers
13. Three‐dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy
14. NA-CONTROL: a study protocol for a randomised controlled trial to compare specific outpatient rehabilitation that targets cerebral mechanisms through relearning motor control and uses self-management strategies to improve functional capability of the upper extremity, to usual care in patients with neuralgic amyotrophy
15. LAMA2-Related Muscular Dystrophy Across the Life Span.
16. The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy.
17. Effectiveness of an outpatient rehabilitation programme in patients with neuralgic amyotrophy and scapular dyskinesia: a randomised controlled trial
18. Facial Function Scale
19. Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype
20. Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis
21. Additional file 3 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
22. Additional file 10 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
23. Additional file 7 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
24. Additional file 2 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
25. Additional file 8 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
26. Additional file 9 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
27. Additional file 6 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
28. Additional file 4 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
29. Additional file 5 of The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
30. Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy
31. MRI in sarcoglycanopathies: a large international cohort study
32. Monitoring creatine and phosphocreatine by 13C MR spectroscopic imaging during and after 13C4 creatine loading: a feasibility study
33. An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
34. Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI : Protocol development, multicenter feasibility, and repeatability
35. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI Composite Scores for Longitudinal and Cross-sectional Analysis
36. Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatability
37. Respiratory muscle function in patients with nemaline myopathy
38. Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype.
39. Muscle cramps and contractures: causes and treatment.
40. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken
41. Effect of Suboptimal Sampling and Handling Conditions on Urinary Metabolic Profiles
42. Additional file 1 of Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood
43. Visuomotor processing is altered after peripheral nerve damage in neuralgic amyotrophy
44. How Persons with a Neuromuscular Disease Perceive Employment Participation: A Qualitative Study
45. Polymyositis, Invasion Of Non-Necrotic Muscle Fibres, And The Art Of Repetition
46. Author response for 'Facioscapulohumeral muscular dystrophy-Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease'
47. Facioscapulohumeral muscular dystrophy—Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease
48. N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
49. The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
50. Natural History of Facioscapulohumeral Dystrophy in Children A 2-Year Follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.